Center for Medical Ethics and Health Policy Staff Publications
Language
English
Publication Date
1-1-2024
Journal
Pediatric Blood & Cancer
DOI
10.1002/pbc.30726
PMID
37856154
PMCID
PMC11905159
PubMedCentral® Posted Date
3-13-2025
PubMedCentral® Full Text Version
Author MSS
Abstract
We evaluated disparities in disease burden, organ dysfunction, vital signs, and timing of therapy in children newly presenting with acute leukemia. Among 899 patients with acute leukemia diagnosed at two large children's hospitals, a priori lab-based definitions of high disease burden, infection risk, renal dysfunction, and coagulopathy were applied to electronic health record data. Black patients with acute myeloid leukemia had increased prevalence of elevated white blood cell count and uric acid; Black patients with acute lymphoblastic leukemia demonstrated increased prevalence of coagulopathy. Black patients' presentation more frequently included multiple lab abnormalities consistent with advanced physiologic dysfunction. No differences were found in days to therapy initiation.
Keywords
Child, Humans, Racial Groups, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Hospitals, Pediatric, Healthcare Disparities, diagnosis, disparities, pediatric leukemia, race
Published Open-Access
yes
Recommended Citation
Winestone, Lena E; Getz, Kelly D; Li, Yimei; et al., "Racial and Ethnic Disparities in Acuity of Presentation Among Children With Newly Diagnosed Acute Leukemia" (2024). Center for Medical Ethics and Health Policy Staff Publications. 180.
https://digitalcommons.library.tmc.edu/med_ethics/180
Included in
Bioethics and Medical Ethics Commons, Health Policy Commons, Medical Sciences Commons, Oncology Commons, Pediatrics Commons